Avience Biomedicals IPO GMP History
Final pre-listing GMP reading: 25 Jun 2026, 5:07 am IST
GMP applies before listing only. The figures below are a historical record of grey market sentiment ahead of the debut on 25 Jun 2026 — see listing performance for the actual outcome.
GMP trend
GMP moved from ₹50 on 15 Jun 2026 to ₹145 on 25 Jun 2026.
Day-wise GMP history
| Date | GMP | Implied Return | Implied Listing |
|---|---|---|---|
| 25 Jun 2026 | ₹145 | +69.7% | ₹353 |
| 24 Jun 2026 | ₹107 | +51.4% | ₹315 |
| 23 Jun 2026 | ₹83 | +39.9% | ₹291 |
| 22 Jun 2026 | ₹70 | +33.6% | ₹278 |
| 21 Jun 2026 | ₹70 | +33.6% | ₹278 |
| 18 Jun 2026 | ₹85 | +40.9% | ₹293 |
| 17 Jun 2026 | ₹75 | +36.1% | ₹283 |
| 16 Jun 2026 | ₹93 | +44.7% | ₹301 |
| 15 Jun 2026 | ₹50 | +24.0% | ₹258 |
GMP is an unofficial figure sourced from grey market dealers and is not a guarantee of the listing price. Provided for information only, not investment advice. How we source GMP · Disclaimer
Reading this GMP history
How the GMP moved
The first grey market reading in our record for the Avience Biomedicals IPO came in at ₹50 on 15 Jun 2026. The final reading before listing was ₹145, dated 25 Jun 2026 — the highest point of the series, roughly +69.7% on the issue price. Start to finish, over 11 days, that is a net rise of ₹95 per share. Day-end readings ranged between ₹50 and ₹145 across 9 days of data — a band of ₹95 that shows how much dealer sentiment shifted while the quote was live.
GMP versus the actual listing
Going into listing day, the final premium of ₹145 implied a debut near ₹353 against the issue price of ₹208. The stock actually debuted at ₹395.2, a listing gain of +90.0% on the issue price. That puts the actual debut ₹42.2 above what the final premium implied — a gap worth noting when weighing how much signal GMP carried for this issue. Every grey market figure on this page is an unofficial number collected from grey-market dealers; it is not published by the company or the exchanges and is not a guarantee of the actual listing price.
Frequently asked questions
- What is the Avience Biomedicals IPO price band?
- The Avience Biomedicals IPO price band is ₹196 to ₹208 per share, with a lot size of 600 shares.
- What was the Avience Biomedicals IPO GMP before listing?
- The final grey market premium recorded before the Avience Biomedicals IPO listed was ₹145. The IPO listed on 25 Jun 2026 at ₹395.2, +90.0% against the issue price. GMP is an unofficial figure and was never a guarantee of the listing price.
- When is the Avience Biomedicals IPO allotment and listing date?
- Allotment is expected on 23 Jun 2026. The shares are scheduled to list on 25 Jun 2026 on NSE.